My NCBI | Sign In
RSS Settings
  • Search:

Display Settings:

Format
Items per page
Sort by

Send to:

Choose Destination

    Results: 1 to 20 of 558

    1.

    Adiponectin in a native Canadian population experiencing rapid epidemiological transition.

    Hanley AJ, Connelly PW, Harris SB, Zinman B.

    Diabetes Care. 2003 Dec;26(12):3219-25.PMID: 14633805 [PubMed - indexed for MEDLINE]Related articlesFree article

    2.

    Cross-sectional and prospective associations between abdominal adiposity and proinsulin concentration.

    Hanley AJ, McKeown-Eyssen G, Harris SB, Hegele RA, Wolever TM, Kwan J, Zinman B.

    J Clin Endocrinol Metab. 2002 Jan;87(1):77-83.PMID: 11788626 [PubMed - indexed for MEDLINE]Related articlesFree article

    3.

    Cross-sectional and prospective associations between proinsulin and cardiovascular disease risk factors in a population experiencing rapid cultural transition.

    Hanley AJ, McKeown-Eyssen G, Harris SB, Hegele RA, Wolever TM, Kwan J, Connelly PW, Zinman B.

    Diabetes Care. 2001 Jul;24(7):1240-7. Erratum in: Diabetes Care 2001 Oct;24(10):1851. PMID: 11423509 [PubMed - indexed for MEDLINE]Related articlesFree article

    4.

    Plasma adiponectin levels in high risk African-Americans with normal glucose tolerance, impaired glucose tolerance, and type 2 diabetes.

    Osei K, Gaillard T, Schuster D.

    Obes Res. 2005 Jan;13(1):179-85.PMID: 15761178 [PubMed - indexed for MEDLINE]Related articles

    5.

    Limited value of the homeostasis model assessment to predict insulin resistance in older men with impaired glucose tolerance.

    Ferrara CM, Goldberg AP.

    Diabetes Care. 2001 Feb;24(2):245-9.PMID: 11213873 [PubMed - indexed for MEDLINE]Related articlesFree article

    6.

    Plasma adiponectin concentration is associated with skeletal muscle insulin receptor tyrosine phosphorylation, and low plasma concentration precedes a decrease in whole-body insulin sensitivity in humans.

    Stefan N, Vozarova B, Funahashi T, Matsuzawa Y, Weyer C, Lindsay RS, Youngren JF, Havel PJ, Pratley RE, Bogardus C, Tataranni PA.

    Diabetes. 2002 Jun;51(6):1884-8.PMID: 12031977 [PubMed - indexed for MEDLINE]Related articlesFree article

    7.

    Association of low adiponectin levels with the metabolic syndrome--the Chennai Urban Rural Epidemiology Study (CURES-4).

    Mohan V, Deepa R, Pradeepa R, Vimaleswaran KS, Mohan A, Velmurugan K, Radha V.

    Metabolism. 2005 Apr;54(4):476-81.PMID: 15798954 [PubMed - indexed for MEDLINE]Related articles

    8.

    High serum resistin is associated with an increase in adiposity but not a worsening of insulin resistance in Pima Indians.

    Vozarova de Courten B, Degawa-Yamauchi M, Considine RV, Tataranni PA.

    Diabetes. 2004 May;53(5):1279-84. Erratum in: Diabetes. 2004 Sep;53(9):2518. Volarova de Courten, B [corrected to Vozarova de Courten, B]. PMID: 15111497 [PubMed - indexed for MEDLINE]Related articlesFree article

    9.

    Hypoadiponectinemia in obesity and type 2 diabetes: close association with insulin resistance and hyperinsulinemia.

    Weyer C, Funahashi T, Tanaka S, Hotta K, Matsuzawa Y, Pratley RE, Tataranni PA.

    J Clin Endocrinol Metab. 2001 May;86(5):1930-5.PMID: 11344187 [PubMed - indexed for MEDLINE]Related articlesFree article

    10.

    Circulating tumor necrosis factor-alpha concentrations in a native Canadian population with high rates of type 2 diabetes mellitus.

    Zinman B, Hanley AJ, Harris SB, Kwan J, Fantus IG.

    J Clin Endocrinol Metab. 1999 Jan;84(1):272-8.PMID: 9920095 [PubMed - indexed for MEDLINE]Related articlesFree article

    11.

    Metabolic syndrome in nondiabetic, obese, first-degree relatives of African American patients with type 2 diabetes: African American triglycerides-HDL-C and insulin resistance paradox.

    Meis SB, Schuster D, Gaillard T, Osei K.

    Ethn Dis. 2006 Autumn;16(4):830-6.PMID: 17061734 [PubMed - indexed for MEDLINE]Related articles

    12.

    The associations between plasma adiponectin, ghrelin levels and cardiovascular risk factors.

    Choi KM, Lee J, Lee KW, Seo JA, Oh JH, Kim SG, Kim NH, Choi DS, Baik SH.

    Eur J Endocrinol. 2004 May;150(5):715-8.PMID: 15132729 [PubMed - indexed for MEDLINE]Related articlesFree article

    13.

    Decreased plasma adiponectin concentrations in nondiabetic women with elevated homeostasis model assessment ratios.

    Matsubara M, Katayose S, Maruoka S.

    Eur J Endocrinol. 2003 Mar;148(3):343-50.PMID: 12611616 [PubMed - indexed for MEDLINE]Related articlesFree article

    14.

    Homeostasis model assessment of insulin resistance in relation to the incidence of cardiovascular disease: the San Antonio Heart Study.

    Hanley AJ, Williams K, Stern MP, Haffner SM.

    Diabetes Care. 2002 Jul;25(7):1177-84.PMID: 12087016 [PubMed - indexed for MEDLINE]Related articlesFree article

    15.

    Increased visceral fat and impaired glucose tolerance predict the increased risk of metabolic syndrome in Japanese middle-aged men.

    Mori Y, Hoshino K, Yokota K, Yokose T, Tajima N.

    Exp Clin Endocrinol Diabetes. 2005 Jun;113(6):334-9.PMID: 15977101 [PubMed - indexed for MEDLINE]Related articles

    16.

    Insulin resistance, beta cell function and cardiovascular risk factors in Ghanaians with varying degrees of glucose tolerance.

    Amoah AG, Schuster DP, Gaillard T, Osei K.

    Ethn Dis. 2002 Fall;12(4):S3-10-7.PMID: 12477148 [PubMed - indexed for MEDLINE]Related articles

    17.

    The effect of thiazolidinediones on plasma adiponectin levels in normal, obese, and type 2 diabetic subjects.

    Yu JG, Javorschi S, Hevener AL, Kruszynska YT, Norman RA, Sinha M, Olefsky JM.

    Diabetes. 2002 Oct;51(10):2968-74.PMID: 12351435 [PubMed - indexed for MEDLINE]Related articlesFree article

    18.

    Glucose-to-insulin ratio rather than sex hormone-binding globulin and adiponectin levels is the best predictor of insulin resistance in nonobese women with polycystic ovary syndrome.

    Ducluzeau PH, Cousin P, Malvoisin E, Bornet H, Vidal H, Laville M, Pugeat M.

    J Clin Endocrinol Metab. 2003 Aug;88(8):3626-31.PMID: 12915646 [PubMed - indexed for MEDLINE]Related articlesFree article

    19.

    Serum adiponectin concentrations predict the developments of type 2 diabetes and the metabolic syndrome in elderly Koreans.

    Choi KM, Lee J, Lee KW, Seo JA, Oh JH, Kim SG, Kim NH, Choi DS, Baik SH.

    Clin Endocrinol (Oxf). 2004 Jul;61(1):75-80.PMID: 15212647 [PubMed - indexed for MEDLINE]Related articles

    20.

    The SNP276G>T polymorphism in the adiponectin (ACDC) gene is more strongly associated with insulin resistance and cardiovascular disease risk than SNP45T>G in nonobese/nondiabetic Korean men independent of abdominal adiposity and circulating plasma adiponectin.

    Jang Y, Lee JH, Kim OY, Koh SJ, Chae JS, Woo JH, Cho H, Lee JE, Ordovas JM.

    Metabolism. 2006 Jan;55(1):59-66.PMID: 16324920 [PubMed - indexed for MEDLINE]Related articles

    Supplemental Content

    Filter your results:

    Find related data

    Recent activity